Pharmabiz15h
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...
From itchy patches to lingering pimples – the 6 marks on your body you MUST see a doctor about
WE all get the odd mark on our bodies now and then, whether it be a dry patch of skin, an odd-looking mole or a frustrating pimple. While these are often harmless, there are times when they could ...